Literature DB >> 19748999

Elastase- and LPS-exposed mice display altered responses to rhinovirus infection.

Umadevi Sajjan1, Shyamala Ganesan, Adam T Comstock, Jee Shim, Qiong Wang, Deepti R Nagarkar, Ying Zhao, Adam M Goldsmith, Joanne Sonstein, Marisa J Linn, Jeffrey L Curtis, Marc B Hershenson.   

Abstract

Viral infection is associated with approximately one-half of acute exacerbations of chronic obstructive pulmonary disease (COPD), which in turn, accelerate disease progression. In this study, we infected mice exposed to a combination of elastase and LPS, a constituent of cigarette smoke and a risk factor for development of COPD, with rhinovirus serotype 1B, and examined animals for viral persistence, airway resistance, lung volume, and cytokine responses. Mice exposed to elastase and LPS once a week for 4 wk showed features of COPD such as airway inflammation and obstruction, goblet cell metaplasia, reduced lung elastance, increased total lung volume, and increased alveolar chord length. In general, mice exposed to elastase or LPS alone showed intermediate effects. Compared with rhinovirus (RV)-infected PBS-exposed mice, RV-infected elastase/LPS-exposed mice showed persistence of viral RNA, airway hyperresponsiveness, increased lung volume, and sustained increases in expression of TNFalpha, IL-5, IL-13, and muc5AC (up to 14 days postinfection). Furthermore, virus-induced IFNs, interferon response factor-7, and IL-10 were deficient in elastase/LPS-treated mice. Mice exposed to LPS or elastase alone cleared virus similar to PBS-treated control mice. We conclude that limited exposure of mice to elastase/LPS produces a COPD-like condition including increased persistence of RV, likely due to skewing of the immune response towards a Th2 phenotype. Similar mechanisms may be operative in COPD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748999      PMCID: PMC2777490          DOI: 10.1152/ajplung.00150.2009

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  53 in total

1.  Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function.

Authors:  J Eller; A Ede; T Schaberg; M S Niederman; H Mauch; H Lode
Journal:  Chest       Date:  1998-06       Impact factor: 9.410

2.  Rhinovirus infection induces mucus hypersecretion.

Authors:  A Yuta; W J Doyle; E Gaumond; M Ali; L Tamarkin; J N Baraniuk; M Van Deusen; S Cohen; D P Skoner
Journal:  Am J Physiol       Date:  1998-06

3.  Predominant TH1 cytokine pattern in peripheral blood from subjects with chronic obstructive pulmonary disease.

Authors:  M Majori; M Corradi; A Caminati; G Cacciani; S Bertacco; A Pesci
Journal:  J Allergy Clin Immunol       Date:  1999-03       Impact factor: 10.793

4.  Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes.

Authors:  P Ray; W Tang; P Wang; R Homer; C Kuhn; R A Flavell; J A Elias
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

5.  Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7.

Authors:  M Sato; N Hata; M Asagiri; T Nakaya; T Taniguchi; N Tanaka
Journal:  FEBS Lett       Date:  1998-12-11       Impact factor: 4.124

6.  Interleukin-13: central mediator of allergic asthma.

Authors:  M Wills-Karp; J Luyimbazi; X Xu; B Schofield; T Y Neben; C L Karp; D D Donaldson
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

7.  Requirement for IL-13 independently of IL-4 in experimental asthma.

Authors:  G Grünig; M Warnock; A E Wakil; R Venkayya; F Brombacher; D M Rennick; D Sheppard; M Mohrs; D D Donaldson; R M Locksley; D B Corry
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

8.  Blood inflammatory response to inhaled endotoxin in normal subjects.

Authors:  O Michel; J Duchateau; G Plat; B Cantinieaux; A Hotimsky; J Gerain; R Sergysels
Journal:  Clin Exp Allergy       Date:  1995-01       Impact factor: 5.018

9.  Grain dust and endotoxin inhalation challenges produce similar inflammatory responses in normal subjects.

Authors:  P J Jagielo; P S Thorne; J L Watt; K L Frees; T J Quinn; D A Schwartz
Journal:  Chest       Date:  1996-07       Impact factor: 9.410

10.  Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis.

Authors:  R Mueller; P Chanez; A M Campbell; J Bousquet; C Heusser; G R Bullock
Journal:  Respir Med       Date:  1996-02       Impact factor: 3.415

View more
  48 in total

1.  Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor A.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Joanne Sonstein; Jeffrey L Curtis; Uma S Sajjan
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

2.  Impact of host proteases on reovirus infection in the respiratory tract.

Authors:  Rachel M Nygaard; Joseph W Golden; Leslie A Schiff
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Hox5 genes direct elastin network formation during alveologenesis by regulating myofibroblast adhesion.

Authors:  Steven M Hrycaj; Leilani Marty-Santos; Cristina Cebrian; Andrew J Rasky; Catherine Ptaschinski; Nicholas W Lukacs; Deneen M Wellik
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

4.  Emphysema induced by elastase enhances acute inflammatory pulmonary response to intraperitoneal LPS in rats.

Authors:  Lídia Maria Carneiro da Fonseca; Maycon Moura Reboredo; Leda Marília Fonseca Lucinda; Thaís Fernanda Fazza; Maria Aparecida Esteves Rabelo; Adenilson Souza Fonseca; Flavia de Paoli; Bruno Valle Pinheiro
Journal:  Int J Exp Pathol       Date:  2016-12-23       Impact factor: 1.925

5.  Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice.

Authors:  Jiusong Sun; Galina K Sukhova; Jie Zhang; Han Chen; Sara Sjöberg; Peter Libby; Meixiang Xiang; Jianan Wang; Christoph Peters; Thomas Reinheckel; Guo-Ping Shi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

6.  Treatment with intranasal iloprost reduces disease manifestations in a murine model of previously established COPD.

Authors:  Matthew R Lammi; Mohamed A Ghonim; Kusma Pyakurel; Amarjit S Naura; Salome V Ibba; Christian J Davis; Samuel C Okpechi; Kyle I Happel; Bennett P deBoisblanc; Judd Shellito; A Hamid Boulares
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-05       Impact factor: 5.464

7.  Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness.

Authors:  Dina Schneider; Jun Y Hong; Antonia P Popova; Emily R Bowman; Marisa J Linn; Alan M McLean; Ying Zhao; Joanne Sonstein; J Kelley Bentley; Jason B Weinberg; Nicholas W Lukacs; Jeffrey L Curtis; Uma S Sajjan; Marc B Hershenson
Journal:  J Immunol       Date:  2012-02-13       Impact factor: 5.422

Review 8.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031

9.  Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Sangbrita S Chattoraj; Asamanja Chattoraj; John R Burgess; Jeffrey L Curtis; Fernando J Martinez; Suzanna Zick; Marc B Hershenson; Uma S Sajjan
Journal:  Respir Res       Date:  2010-09-28

10.  TLR2 Activation Limits Rhinovirus-Stimulated CXCL-10 by Attenuating IRAK-1-Dependent IL-33 Receptor Signaling in Human Bronchial Epithelial Cells.

Authors:  Shyamala Ganesan; Duc Pham; Yaxun Jing; Mohammad Farazuddin; Magdalena H Hudy; Benjamin Unger; Adam T Comstock; David Proud; Adam S Lauring; Uma S Sajjan
Journal:  J Immunol       Date:  2016-08-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.